202 related articles for article (PubMed ID: 24239629)
1. Anti-hepatoma human single-chain Fv antibody and adriamycin conjugates with potent antitumor activity.
Chen L; Liu YH; Li YH; Jiang Y; Xie PL; Zhou GH; Li GC
Int Immunopharmacol; 2014 Jan; 18(1):20-6. PubMed ID: 24239629
[TBL] [Abstract][Full Text] [Related]
2. Expression of scFv SA3 against hepatoma fused with enhanced green fluorescent protein and its targeted ability in vivo.
Huang J; Li Y; Guo F; Tong Y; Wang J; Hu J; Li G
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Oct; 36(10):979-86. PubMed ID: 22086009
[TBL] [Abstract][Full Text] [Related]
3. [Targeting therapy with adriamycin-monoclonal antibody (HAb18) conjugate in nude mice with human hepatocellular carcinoma xenografts].
Sui Y
Zhonghua Yi Xue Za Zhi; 1992 Jul; 72(7):397-400, 445. PubMed ID: 1330227
[TBL] [Abstract][Full Text] [Related]
4. [Selection and characterization of human scFv antibodies against hepatocellular carcinoma].
Huang J; Xiao Y; Tong YQ; Guo FJ; Zhou GH; Li YH; Hu JY; Li GC
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Mar; 24(3):256-9. PubMed ID: 18328187
[TBL] [Abstract][Full Text] [Related]
5. [The antitumor effect of adriamycin conjugated with monoclonal antibody against gastric cancer in vitro and in vivo].
Zhang YT; Wang NQ; Li N; Liu T; Dong ZW
Yao Xue Xue Bao; 1992; 27(5):325-30. PubMed ID: 1442051
[TBL] [Abstract][Full Text] [Related]
6. [Growth inhibitory effect of adriamycin conjugated to single-chain antibody on human lung adenocarcinoma in vitro].
Yue WT; Lai BT; Wang H; Zhan XP; Wang Y
Zhonghua Zhong Liu Za Zhi; 2004 Dec; 26(12):718-21. PubMed ID: 15733387
[TBL] [Abstract][Full Text] [Related]
7. Ad-KDRscFv:sTRAIL displays a synergistic antitumor effect without obvious cytotoxicity to normal tissues.
Yang L; Guo J; Wang J; Wan S; Yang S; Wang R; Chen W; Peng G; Fang D
Int Immunopharmacol; 2012 May; 13(1):37-45. PubMed ID: 22406047
[TBL] [Abstract][Full Text] [Related]
8. An EGFR/CD13 bispecific fusion protein and its enediyne-energized analog show potent antitumor activity.
Sheng W; Shang Y; Li L; Zhen Y
Anticancer Drugs; 2014 Jan; 25(1):82-91. PubMed ID: 24100279
[TBL] [Abstract][Full Text] [Related]
9. [Antitumor effect of nanospheres coupled with the anti-human liver cancer monoclonal antibody HAb18].
Kan HP; Liu ZJ; Tan YF; Lin YX; Li CF; Zhou J
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1503-5. PubMed ID: 18753092
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of humanized anti-VEGFR-2 ScFv-As2O3-stealth nanoparticles conjugate on growth of human hepatocellular carcinoma: in vitro and in vivo studies.
Yin XB; Wu LQ; Fu HQ; Huang MW; Wang K; Zhou F; Yu X; Wang KY
Asian Pac J Trop Med; 2014 May; 7(5):337-43. PubMed ID: 25063057
[TBL] [Abstract][Full Text] [Related]
11. Antitumor efficacy of the scFv-based fusion protein and its enediyne-energized analogue directed against epidermal growth factor receptor.
Sheng W; Shang Y; Miao Q; Li Y; Zhen Y
Anticancer Drugs; 2012 Apr; 23(4):406-16. PubMed ID: 22205154
[TBL] [Abstract][Full Text] [Related]
12. A Gelatinases-targeting scFv-based Fusion Protein Shows Enhanced Antitumour Activity with Endostar against Hepatoma.
Gao R; Li L; Shang B; Zhao C; Sheng W; Li D
Basic Clin Pharmacol Toxicol; 2015 Aug; 117(2):105-16. PubMed ID: 25615234
[TBL] [Abstract][Full Text] [Related]
13. [Preparation of heat shock protein 70 (Hsp70) and idiotypic determinant single-chain antibody (Id-ScFv) in a patient with B-cell chronic lymphatic leukemia (B-CLL) and antitumor effect of peptide complex Hsp70-Id].
Ye Q; Wang ZH; Qin SK
Ai Zheng; 2008 Feb; 27(2):133-8. PubMed ID: 18279608
[TBL] [Abstract][Full Text] [Related]
14. Primary targeting of recombinant Fv-immunotoxin hscFv(25)-mTNFalpha against hepatocellular carcinoma.
Zhang J; Liu YF; Yang SJ; Qiao Q; Cheng H; Zhang CS; Ma FC; Guo HZ
World J Gastroenterol; 2004 Jul; 10(13):1872-5. PubMed ID: 15222026
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity of adriamycin (hydrazone-linked) immunoconjugates compared with free adriamycin and specificity of tumor cell killing.
Braslawsky GR; Edson MA; Pearce W; Kaneko T; Greenfield RS
Cancer Res; 1990 Oct; 50(20):6608-14. PubMed ID: 2208123
[TBL] [Abstract][Full Text] [Related]
16. Nanocell targeting using engineered bispecific antibodies.
Taylor K; Howard CB; Jones ML; Sedliarou I; MacDiarmid J; Brahmbhatt H; Munro TP; Mahler SM
MAbs; 2015; 7(1):53-65. PubMed ID: 25523746
[TBL] [Abstract][Full Text] [Related]
17. [Importance of the conjugated antibody for the induction of selective effect of adriamycin conjugated with anti AFP monoclonal antibody and entrapped in liposomes against AFP producing tumors].
Konno H; Kumai K; Tsubouchi T; Ishibiki K; Abe O; Tadakuma T; Yasuda T; Nagaike K; Hosokawa S; Sakaguchi S
Gan To Kagaku Ryoho; 1989 Jun; 16(6):2213-7. PubMed ID: 2472119
[TBL] [Abstract][Full Text] [Related]
18. [Experimental studies on targeting chemotherapy using adriamycin entrapped in liposomes conjugated with anti-human alpha-fetoprotein monoclonal antibody].
Suzuki H
Nihon Geka Gakkai Zasshi; 1991 Mar; 92(3):257-65. PubMed ID: 1711147
[TBL] [Abstract][Full Text] [Related]
19. A conjugate of an anti-midkine single-chain variable fragment to doxorubicin inhibits tumor growth.
Zhao S; Zhao G; Xie H; Huang Y; Hou Y
Braz J Med Biol Res; 2012 Mar; 45(3):230-7. PubMed ID: 22267001
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activities of dFv-LDP-AE: An enediyne-energized fusion protein targeting tumor-associated antigen gelatinases.
Zhong GS; Wu MN; Guo XF; Zhang SH; Miao QF; Zhen YS
Oncol Rep; 2012 Oct; 28(4):1193-9. PubMed ID: 22797730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
